Previous studies havefocused on inhibiting activation of (mTOR)/S6K pathway which have only limited efficacy for treatment of psoriasis but recent findings on the mechanism underlying hyper-translation have highlighted involvement of proteins besides canonical mTOR targets [8].Therefore by targeting definite stages of translation initiation, elongation or termination, novel therapeutic responses may be obtained. Here, MTOR is linked to psoriasis.